Abstract:DddA-derived cytosine base editors (DdCBEs) enable the targeted introduction of C·G-to-T·A conversions in mitochondrial DNA (mtDNA). DdCBEs are often deployed as pairs, with each arm comprised of a transcription activator-like effector (TALE), a split double-stranded DNA deaminase half, and a uracil glycosylase inhibitor. This pioneering technology has helped improve our understanding of cellular processes involving mtDNA and has paved the way for the development of models and therapies for genetic disorders caused by pathogenic mtDNA variants. Nonetheless, given the intrinsic properties of TALE proteins, several target sites in human mtDNA remain out of reach to DdCBEs and other TALE-based technologies. Specifically, due to the conventional requirement for a thymine immediately upstream of the TALE target sequences (i.e., the 5′-T constraint), over 150 loci in the human mitochondrial genome are presumed to be inaccessible to DdCBEs. Previous attempts at circumventing this constraint, either by developing monomeric DdCBEs or utilizing DNA-binding domains alternative to TALEs, have resulted in suboptimal specificity profiles with reduced therapeutic potential. Here, aiming to challenge and elucidate the relevance of the 5′-T constraint in the context of DdCBE-mediated mtDNA editing, and to expand the range of motifs that are editable by this technology, we generated αDdCBEs that contain modified TALE proteins engineered to recognize all 5′ bases. Notably, 5′-T-noncompliant, canonical DdCBEs efficiently edited mtDNA at diverse loci. However, DdCBEs were frequently outperformed by αDdCBEs, which consistently displayed significant improvements in activity and specificity, regardless of the 5′-most bases of their TALE binding sites. Furthermore, we showed that αDdCBEs are compatible with DddAtox and its derivatives DddA6, and DddA11, and we validated TALE shifting with αDdCBEs as an effective approach to optimize base editing outcomes at a single target site. Overall, αDdCBEs enable efficient, specific, and unconstrained mitochondrial base editing.

Mitochondrial DNA editing in potato through mitoTALEN and mitoTALECD: molecular characterization and stability of editing events

The Development of Mitochondrial Gene Editing Tools and Their Possible Roles in Crop Improvement for Future Agriculture

Recent Advances in Molecular Improvement for Potato Tuber Traits

Induction of Targeted, Heritable Mutations in Barley and Brassica Oleracea Using RNA-guided Cas9 Nuclease

Research Progress in Mitochondrial Gene Editing Technology.

Curing cytoplasmic male sterility via TALEN-mediated mitochondrial genome editing

Transcription Activator-Like Effector Nucleases (TALEN)-Mediated Targeted DNA Insertion in Potato Plants

Mitochondrial DNA editing in mice with DddA-TALE fusion deaminases

The Solanum tuberosum GBSSI gene: a target for assessing gene and base editing in tetraploid potato

Tools for editing the mammalian mitochondrial genome

In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue

Epigenome Editing Of Potato By Grafting Using Transgenic Tobacco As Sirna Donor

Unconstrained Precision Mitochondrial Genome Editing with αDdCBEs

Engineered mitochondrial A-to-G editors with enhanced efficiency and targeting scope

Strand-selective base editing of human mitochondrial DNA using mitoBEs

Transfer of Mitochondrial DNA into the Nuclear Genome During Induced DNA Breaks

Genome editing of plant mitochondrial and chloroplast genomes

High-efficiency plastome base editing in rice with TAL cytosine deaminase

The FusX TALE Base Editor (FusXTBE) for Rapid Mitochondrial DNA Programming of Human Cells In Vitro and Zebrafish Disease Models In Vivo

Streamlined process for effective and strand-selective mitochondrial base editing using mitoBEs

Targeted C•G-to-T•A base editing with TALE-cytosine deaminases in plants